WebMD/DuPont
Executive Summary
WebMD CEO Martin Wygod ends revenue-sharing agreement under which DuPont would have been the exclusive supplier of health information to WebMD's website (1"The Pink Sheet" April 12, 1999, p. 24)
You may also be interested in...
DuPont Becomes Consumer Health Information Provider With WebMD Alliance
DuPont Pharmaceuticals will launch its Digital Consumer Health business through an agreement to provide consumer health information to WebMD for distribution on its internet site.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials